Endomysium antibody (EMA) IVD, kit, fluorescent immunoassay

Endomysium antibody (EMA) IVD kits use fluorescent immunoassay technology to detect anti-EMA antibodies in patient samples, primarily for diagnosing celiac disease. These tests analyze serum or plasma to identify autoimmune markers linked to intestinal damage in affected individuals, supporting early diagnosis and treatment planning.

These kits are typically regulated as in vitro diagnostics (IVDs) and may require compliance with standards like ISO 15189 or FDA 21 CFR Part 820, depending on the jurisdiction. They are generally supplied as complete reagent sets, including controls, conjugates, and substrates, requiring minimal additional laboratory infrastructure for use.